Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Priority in the therapeutic use of X-rays.Radiology. 1933; 21: 156-162
- Deep inspiration breath hold: techniques and advantages for cardiac sparing during breast cancer irradiation.Front Oncol. 2018; 8: 87
- Prone whole-breast irradiation using three-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent to good cosmetic outcomes in patients with large and/or pendulous breasts.Int J Radiat Oncol Biol Phys. 2012; 83: 3
- Proton therapy for breast cancer: a consensus statement from the particle therapy cooperative group bresat cancer subdommittee.Int J Radiat Oncol Biol Phys. 2021; 111: 337-359
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10801 women in 17 randomised trials.Lancet. 2011; 378: 1707-1716
- Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.J Clin Oncol. 2013; 31: 2382-2387
- Prime 2 Randomised trial (postoperative radiotherapy in minimum-risk elderly): wide local excision and adjuvant hormonal therapy +/- whole breast irradiation in women =/> 65 years with early invasive breast cancer: 10 year results.Cancer Res. 2021; 81: GS2-03
- Long-term results of hypofractionated radiation therapy for breast cancer.N Engl J Med. 2010; 362: 513-520
- The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.Lancet Oncol. 2013; 14: 1086-1094
- Advances in breast cancer radiotherapy: implications for current and future practice.JCO Oncol Pract. 2021; 17: 697-706
- Radiation therapy for the whole breast: executive summary of an american society for radiation oncology (ASTRO) evidence-based guideline.Pracital Radiat Oncol. 2018; 8: 145-152
- Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.Lancet. 2020; 395: 1613-1626
- Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer.J Clin Oncol. 2020; 38: 3261-3272
- Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: considerations regarding FAST and FAST-forward.Strahlenther Onkol. 2021; 197: 269-280
- ClinicalTrials.gov. 2022;
- Long-term Primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a radndomised, phase 3, equivalence trial.Lancet. 2019; 394: 2155-2164
- Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement.Pract Radiat Oncol. 2017; 7: 73-79
- Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-florence trial.J Clin Oncol. 2020; 38: 4175-4183
- Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year Results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.Lancet. 2017; 390: 1048-1060
- Long term survival and local control outocomes from a single dose targeted intraoperative radiotherapy durin gLumpectomy (TARGIT_IORT) for early breast cancer: TARGIT-A randomised clinical trial.BMJ. 2020; 370: m2836https://doi.org/10.1136/bmj.m2836
- Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial.Lancet Oncol. 2021; 22: 597-608
- Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.J Natl Cancer Inst Monographs. 2010; 41: 162-177
- Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.J Natl Cancer Inst. 2011; 103: 478-488
- Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from NRG oncology/RTOG 0984.J Clin Oncol. 2021; 39: 3574-3582
- Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study.J Clin Oncol. 2015; 33: 2938-2944
- A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.J Natl Cancer Inst. 2013; 105: 701-710
- Validation of a ductal carcinoma in situ biomarker profile for risk of recurrence after breast-conserving surgery with and without radiotherapy.Clin Cancer Res. 2020; 26: 4054-4063
- Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomized trials.Lancet. 2014; 383: 2127-2135
- Regional nodal irradiation in early-stage breast cancer.N Engl J Med. 2015; 373: 307-316
- Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC22922/10925): 15-year results of a randomised, phase 3 trial.Lancet Oncol. 2020; 21: 1602-1610
- Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: 10 year follow up results of the EORTC AMAROS trial (EORTC 10981/22023).Cancer Res. 2019; 79 (GS4–01)
- Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis the ACOSOG Z0011 (Alliance) randomized clinical trial.JAMA. 2017; 318: 918-926
- Radiation field design in the ACOSOG Z0011 (Alliance) trial.J Clin Oncol. 2014; 32: 3600-3606
- Effect of elective internal mammary node irradiation on disease-free survival in women with node-positive breast cancer.JAMA Oncol. 2022; 8: 96-105
- Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials.J Clin Oncol. 2017; 35: 1641-1649
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.Lancet. 2005; 366: 2087-2106
- The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study.Int J Radiat Oncol Biol Phys. 2014; 88: 565-571
- Radiotherapy in the setting of breast reconstruction: types, techniques, and timing.Lancet Oncol. 2017; 18: e742-e753
- Breast cancer conservation therapy. [Updated 2021 Sep 22]. In: StatPearls [Internet]. Treasure Island (FL).StatPearls Publishing, 2022 (Available at:)
Article info
Publication history
Published online: October 17, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
